asthma
Conditions
Interventions
control group:placebo
Sponsors
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnosis and severity grade of bronchial asthma in the Guidelines for The Prevention and Treatment of Bronchial Asthma (2016 edition) formulated by the Asthma Group, Respiratory Division, Chinese Medical Association; 2. It conforms to the diagnosis of asthma of traditional Chinese medicine, and the syndrome differentiation of traditional Chinese medicine belongs to the deficiency of kidney; 3. Patients aged between 18 and 75 who voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Grade 3 ~ 4 patients with acute onset or chronic duration of bronchial asthma; 2. Pulmonary infection, bronchiectasis, pulmonary heart disease, respiratory failure, pulmonary hypertension and other diseases; 3. Patients with severe diseases or mental diseases such as malignant tumors, cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic diseases, diabetes, etc.; 4. Women planning pregnancy, pregnancy or breastfeeding; 5. Those who are known to be allergic to the ingredients of this drug; 6. Poor compliance and impaired speech and communication; 7. Patients participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-6;TGF-beta;IL-17; | — |
Countries
China
Contacts
Public ContactBidan Xiong
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed